The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksFlutter Entertainment Regulatory News (FLTR)

Share Price Information for Flutter Entertainment (FLTR)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 14,910.00
Bid: 14,800.00
Ask: 14,810.00
Change: -25.00 (-0.17%)
Spread: 10.00 (0.068%)
Open: 14,805.00
High: 14,915.00
Low: 14,640.00
Prev. Close: 14,935.00
FLTR Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Result of shareholder consultation

24 Mar 2023 14:01

RNS Number : 1871U
Flutter Entertainment PLC
24 March 2023
 

24 March 2023

 

Flutter Entertainment plc (the "Company")

Result of shareholder consultation on additional US listing

 

On 14 February 2023 Flutter announced it would be consulting with shareholders on an additional US listing of the Group's ordinary shares and set out the long-term strategic benefits. Having consulted widely with shareholders representing a significant majority of Flutter's issued share capital and received very strong support, the Flutter Board is pleased to announce that a formal resolution will be put to shareholders on this proposal at the forthcoming AGM on 27 April 2023.

The resolution comprises a number of changes to Flutter's articles of association necessary to facilitate the additional US listing. Accordingly, the resolution requires the approval of 75% of the votes cast by Flutter shareholders in person or by proxy. Should shareholders approve the resolution at the AGM, Flutter will aim to implement the additional US listing during Q4 2023.

 

Contacts:

Investor Relations:

 

Paul Tymms, Director of IR and FP&A

+ 44 75 5715 5768

Ciara O'Mullane, Investor Relations

+ 353 87 947 7862

Liam Kealy, Investor Relations

+ 353 87 665 2014

Press:

 

Kate Delahunty, Chief Communications Officer

+ 44 78 1077 0165

Lindsay Dunford, Corporate Communications

+ 44 79 3197 2959

Rob Allen, Corporate Communications

+ 44 75 5444 1363

Billy Murphy, Drury Communications

+ 353 1 260 5000

James Murgatroyd, Finsbury

+ 44 20 7251 380

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
FURFLFELVLISFIV
Date   Source Headline
24th Apr 20244:00 pmRNSBlock Listing Interim Review
23rd Apr 202410:00 amRNSNotice of Q1 Results
22nd Apr 20246:25 pmRNSHolding(s) in Company
17th Apr 20246:25 pmRNSPricing of Senior Secured Notes
16th Apr 20249:30 amRNSLaunch of offering of Senior Secured Notes
10th Apr 20246:30 pmRNSHolding(s) in Company
10th Apr 20246:25 pmRNSHolding(s) in Company
4th Apr 20244:30 pmRNSDirector/PDMR Shareholding
2nd Apr 20244:00 pmRNSTotal Voting Rights
2nd Apr 20242:30 pmRNSDirector/PDMR Shareholding
2nd Apr 20242:00 pmRNSPublication of Notice of 2024 AGM
28th Mar 20246:00 pmRNSDirector/PDMR Shareholding
26th Mar 20246:00 pmRNSPublication of Annual Report and Accounts 2023
19th Mar 20245:00 pmRNSNotice of 2023 Preliminary Results
15th Mar 20242:00 pmRNSCredit Agreement Amendment
14th Mar 20242:00 pmRNSBlock Listing Application
1st Mar 20243:00 pmRNSTotal Voting Rights
1st Mar 20242:00 pmRNSDirectorate Change and Board Committee Composition
29th Feb 202411:58 amRNSInformation on IFRS to U.S. GAAP transition
13th Feb 20246:15 pmRNSDirector Declaration
6th Feb 20245:30 pmRNSDirector Declaration
1st Feb 20244:00 pmRNSTotal Voting Rights
29th Jan 202412:30 pmRNSFlutter commences trading on the NYSE
24th Jan 20247:00 amRNSSuspension of Trading on Euronext Listing
18th Jan 20247:00 amRNSQ4 2023 Trading Update
11th Jan 202410:00 amRNSDirectorate Change
2nd Jan 202412:00 pmRNSTotal Voting Rights
19th Dec 20236:00 pmRNSHolding(s) in Company
18th Dec 20235:30 pmRNSHolding(s) in Company
14th Dec 20235:00 pmRNSHolding(s) in Company
12th Dec 20236:30 pmRNSHolding(s) in Company
8th Dec 20234:00 pmRNSHolding(s) in Company
8th Dec 20237:00 amRNSUS listing update and Notice of Q4 trading update
6th Dec 20235:00 pmRNSHolding(s) in Company
1st Dec 20231:30 pmRNSTotal Voting Rights
1st Dec 20231:00 pmRNSHolding(s) in Company
29th Nov 20231:00 pmRNSHolding(s) in Company
28th Nov 20231:06 pmRNSHolding(s) in Company
27th Nov 202310:00 amRNSHolding(s) in Company
24th Nov 202310:30 amRNSHolding(s) in Company
23rd Nov 20235:00 pmRNSHolding(s) in Company
22nd Nov 202312:00 pmRNSHolding(s) in Company
17th Nov 20235:30 pmRNSHolding(s) in Company
16th Nov 202310:00 amRNSHolding(s) in Company
15th Nov 20233:30 pmRNSHolding(s) in Company
15th Nov 20233:00 pmRNSDirector/PDMR Shareholding
9th Nov 20232:00 pmRNSBoard Committee Composition
9th Nov 20237:00 amRNSQ3 2023 Trading Update
3rd Nov 202311:00 amRNSHolding(s) in Company
1st Nov 20234:00 pmRNSTotal Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.